Mink Therapeutics
Price & Volume
Stats
See more52W Range | $8.48-$30.64 |
Market Cap | $55M |
Shares Short | 112,459 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.80 |
News
See moreYahoo Finance • 2 months ago
MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026
Yahoo Finance • 3 months ago
MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer
Yahoo Finance • 3 months ago
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
Yahoo Finance • 4 months ago
Wall Street Stabilizes After Oil-Driven Volatility as US Equity Futures Waver Pre-Bell
About
CEO | Dr. Jennifer S. Buell Ph.D. |
Address | 149 Fifth Avenue, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |